24 results
8-K
EX-10.2
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
the liability of any person for any liability which cannot be limited or excluded by law.
Neither Party shall have any right to offset or credit any
8-K
EX-10.1
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
by the Indemnified Party, net of any expenses incurred by such Indemnified Party in collecting such amount, to the extent not previously offset against
DEFM14A
ELYM
Eliem Therapeutics Inc
4 Jun 24
Proxy related to merger
8:00am
, partially offset by foreign exchange losses.
For the Period from November 08, 2023 (Inception) through December 31, 2023
The following table
PREM14A
ELYM
Eliem Therapeutics Inc
17 May 24
Preliminary proxy related to merger
4:36pm
, partially offset by foreign exchange losses.
For the Period from November 08, 2023 (Inception) through December 31, 2023
The following table
10-K
k9uv9sc fq663xrzs
7 Mar 22
Annual report
4:03pm
10-Q
kb39dhxhc46p25
13 Sep 21
Quarterly report
4:01pm
424B4
zpd07mpfqnhju
11 Aug 21
Prospectus supplement with pricing info
5:05pm
S-1/A
w8fdj8k 19jd6ojos
2 Aug 21
IPO registration (amended)
6:08am
S-1
k9qr qfjc
16 Jul 21
IPO registration
5:02pm